Key facts
- This page summarizes Harith Rajagopalan's Form 4 filing for FRACTYL HEALTH, INC. (GUTS).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2025, 18:04.
Harith Rajagopalan - 30 Jan 2025 Form 4 Insider Report for FRACTYL HEALTH, INC. (GUTS)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- GUTS
- Reported as of
- 30 Jan 2025
- Net transaction value
- -$15,739
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2025, 18:04:37 UTC
- Prior SEC filing
- 13 Nov 2024
- Next SEC filing
- 03 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa A. Davidson, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Harith Rajagopalan filed Form 4 for FRACTYL HEALTH, INC. (GUTS) on 03 Feb 2025.
Change
- Previous filing in this sequence was filed on 13 Nov 2024.
- Current net transaction value: -$15,739.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GUTS
transaction
Common Stock
Options Exercise
- Transaction value
- $35,612
- Shares
- +20,948
- Change %
- +4.3%
- Price
- $1.70
- Shares after
- 512,277
- Date
- 30 Jan 2025
- Ownership
- Direct
GUTS
transaction
Common Stock
Sale
- Transaction value
- $40,798
- Shares
- -20,948
- Change %
- -4.1%
- Price
- $1.95
- Shares after
- 491,329
- Date
- 30 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
GUTS
transaction
Common Stock
Options Exercise
- Transaction value
- $154,652
- Shares
- +90,972
- Change %
- +19%
- Price
- $1.70
- Shares after
- 582,301
- Date
- 31 Jan 2025
- Ownership
- Direct
GUTS
transaction
Common Stock
Sale
- Transaction value
- $165,205
- Shares
- -90,972
- Change %
- -16%
- Price
- $1.82
- Shares after
- 491,329
- Date
- 31 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F3
GUTS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 292,171
- Date
- 30 Jan 2025
- Ownership
- By 2021 Irrevocable Trust
GUTS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 292,170
- Date
- 30 Jan 2025
- Ownership
- By 2016 Irrevocable Trust
GUTS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,639
- Date
- 30 Jan 2025
- Ownership
- By 2021 Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GUTS
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -20,948
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 102,536
- Date
- 30 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,948
- Exercise price
- $1.70
- Footnotes
- F4
GUTS
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -90,972
- Change %
- -89%
- Price
- $0.000000
- Shares after
- 11,564
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 90,972
- Exercise price
- $1.70
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9100 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The option is fully vested and exercisable.